Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio Composition
PHILADELPHIA, Sept. 5, 2013 /PRNewswire/ -- Aberdeen Israel Fund, Inc. (the "Fund") (NYSE MKT: ISL), a closed-end equity fund, announced today its performance data and portfolio composition as of July 31, 2013.
(Logo: http://photos.prnewswire.com/prnh/20121106/NE07292LOGO )
The Fund's total returns for various periods through July 31, 2013 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
|
Cumulative as of 07/31/13 |
Annualized as of 07/31/13 | |||||||
|
1 Month |
3 Month |
YTD |
1 Year |
3 Years |
5 Years |
10 Years |
Since Inception | |
|
NAV |
5.1 |
4.9 |
13.6 |
31.2 |
7.8 |
5.9 |
10.3 |
7.3 |
|
Market Price |
2.7 |
5.3 |
14.9 |
29.1 |
6.0 |
4.8 |
10.4 |
6.4 |
|
TA-100 |
5.1 |
4.9 |
13.6 |
27.4 |
6.7 |
5.3 |
10.0 |
7.2 |
On July 31, 2013, the Fund's net assets amounted to US$74.3 million and the Fund's NAV per share was $17.60.
As of July 31, 2013, the portfolio was invested as follows:
|
Portfolio Composition |
Percent of Net Assets |
|
Financials |
22.7 |
|
Health Care |
18.1 |
|
Information Technology |
18.0 |
|
Consumer Staples |
15.1 |
|
Materials |
15.0 |
|
Telecommunications |
4.6 |
|
Industrials |
3.3 |
|
Consumer Discretionary |
2.1 |
|
Cash |
1.2 |
The Fund's ten largest equity holdings as of July 31, 2013, representing 66.8% of net assets, were:
|
Stock |
Percent of Net Assets |
|
Check Point Software Technologies |
10.8 |
|
Teva Pharmaceutical Industries |
9.1 |
|
Perrigo |
8.9 |
|
OSEM Investment |
6.8 |
|
Israel Chemicals |
6.5 |
|
Frutarom Industries |
5.9 |
|
United Mizrahi Bank |
4.9 |
|
Azrieli Group |
4.7 |
|
Rami Levi Chain Stores |
4.6 |
|
Bezeq Israeli Telecommunication |
4.6 |
Important Information
Aberdeen Asset Management Inc. has prepared this report based on information sources believed to be accurate and reliable. However, the figures are unaudited and neither the Fund, Aberdeen Asset Managers Limited (effective March 1, 2012, the Investment Adviser), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information. Aberdeen is a U.S. registered service mark of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that the Fund will achieve its investment objective.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date October 29, 1992.
If you wish to receive this information electronically, please contact: InvestorRelations@aberdeen-asset.com
SOURCE Aberdeen Israel Fund, Inc.
RELATED LINKS
http://www.aberdeenisl.com
More by this Source
Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio Composition
Oct 01, 2013, 11:50 ET
Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio Composition
Aug 02, 2013, 14:24 ET
Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio Composition
Jul 11, 2013, 10:23 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.




